Seegene, Inc. ("Seegene"), a global leader in molecular diagnostics, announced today that its U.S. subsidiary, Seegene USA, Inc. ("Seegene USA"), has received an Emergency Use Authorization (EUA) from ...
Adding the PCR antibody testing could tell us a little more about where in the course of the virus the patient is. But in terms of acute infection, the antibody testing is not going to give us the ...
Because of its high accuracy, laboratory-based polymerase chain reaction (PCR) testing is the gold standard for infectious disease diagnostics. However, PCR technology requires highly trained staff ...
Virus-only testing may miss pneumonia-associated bacterial co-detections in 78% of virus-positive cases, while bacteria-only testing may miss viral co-detections in 88% of cases positive for pneumonia ...
Over the past four years, many of us have become accustomed to a swab up the nose to test for COVID-19, using at-home rapid antigen tests or the more accurate clinic-provided PCR tests with a longer ...
Please provide your email address to receive an email when new articles are posted on . University CMV testing among newborns is not common. In Minnesota, the first state with universal CMV testing, a ...
The COVID-19 pandemic yielded important advances in testing for respiratory viruses, but it also exposed important unmet needs in screening to prevent the spread of infections in high-risk settings.
Real-time PCR enables faster Mycoplasma detection to meet rigorous cell therapy safety standards and reduce quality control-related workflow delays. Cell therapy innovation is accelerating, but ...
Seegene is launching the Global Million Clinical Study at the scale of one million test cases to shape disease-specific testing standards.The study is designed to evaluate the clinical utility of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results